DE69600280D1 - Verfahren zur Herstellung von einem 2-substituierten 3,3-Difluorfuran - Google Patents
Verfahren zur Herstellung von einem 2-substituierten 3,3-DifluorfuranInfo
- Publication number
- DE69600280D1 DE69600280D1 DE69600280T DE69600280T DE69600280D1 DE 69600280 D1 DE69600280 D1 DE 69600280D1 DE 69600280 T DE69600280 T DE 69600280T DE 69600280 T DE69600280 T DE 69600280T DE 69600280 D1 DE69600280 D1 DE 69600280D1
- Authority
- DE
- Germany
- Prior art keywords
- difluorofuran
- substituted
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/410,258 US5633367A (en) | 1995-03-24 | 1995-03-24 | Process for the preparation of a 2-substituted 3,3-difluorofuran |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69600280D1 true DE69600280D1 (de) | 1998-06-18 |
DE69600280T2 DE69600280T2 (de) | 1998-10-08 |
Family
ID=23623945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69600280T Expired - Lifetime DE69600280T2 (de) | 1995-03-24 | 1996-03-12 | Verfahren zur Herstellung von einem 2-substituierten 3,3-Difluorfuran |
Country Status (7)
Country | Link |
---|---|
US (1) | US5633367A (de) |
EP (1) | EP0735043B1 (de) |
JP (1) | JPH08269081A (de) |
CA (1) | CA2171522A1 (de) |
DE (1) | DE69600280T2 (de) |
DK (1) | DK0735043T3 (de) |
ES (1) | ES2117893T3 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2276515T3 (es) * | 1998-02-25 | 2007-06-16 | Emory University | 2'-fluoronucleosidos. |
US7214791B2 (en) * | 2004-07-01 | 2007-05-08 | Shenzhen Hande Technology Co., Ltd. | Method for preparation of 2′-deoxy-2′, 2′-difluoro-β-cytidine or pharmaceutically acceptable salts thereof by using 1,6-anhydro-β-d-glucose as raw material |
KR20080099263A (ko) * | 2006-02-07 | 2008-11-12 | 케마지스 리미티드 | 젬시타빈 및 관련된 중간체의 제조 방법 |
US20070249823A1 (en) * | 2006-04-20 | 2007-10-25 | Chemagis Ltd. | Process for preparing gemcitabine and associated intermediates |
US20080262215A1 (en) * | 2007-04-23 | 2008-10-23 | Chemagis Ltd. | Gemcitabine production process |
BR112021009988A2 (pt) * | 2018-11-25 | 2021-08-17 | Tnt Medical Corporation | composto de fórmula (i), ou um n-óxido deste, ou um sal, solvato, polimorfo, tautômero, estereoisômero farmaceuticamente aceitável, uma forma isotópica, ou um pró-fármaco do dito composto de fórmula (i) ou n-óxido deste, composição farmacêutica, e método de tratamento de uma doença neoplásica |
GB202203421D0 (en) * | 2022-03-11 | 2022-04-27 | Laevoroc Chemotherapy Ag | Orally active prodrug of gemcitabine |
CN115745953B (zh) * | 2022-06-29 | 2024-06-11 | 上海凌凯医药科技有限公司 | 一种羟基氟代试剂及羟基氟代方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4526988A (en) * | 1983-03-10 | 1985-07-02 | Eli Lilly And Company | Difluoro antivirals and intermediate therefor |
KR910008800B1 (ko) * | 1987-03-19 | 1991-10-21 | 야마사 쇼오유 가부시끼가이샤 | 2'-알킬리덴 피리미딘 누클레오시드 유도체, 그 제조법, 및 그 용도 |
US5223608A (en) * | 1987-08-28 | 1993-06-29 | Eli Lilly And Company | Process for and intermediates of 2',2'-difluoronucleosides |
US4965374A (en) * | 1987-08-28 | 1990-10-23 | Eli Lilly And Company | Process for and intermediates of 2',2'-difluoronucleosides |
US4921950A (en) * | 1988-06-09 | 1990-05-01 | Burroughs Wellcome Co. | Preparation of 3'azido-3-'-deoxythymidine |
FI932871A (fi) * | 1992-06-22 | 1993-12-23 | Lilly Co Eli | Stereoselektiv anjonglykosylationsprocess |
KR100252451B1 (ko) * | 1992-09-01 | 2000-04-15 | 피터 지. 스트링거 | 뉴클레오사이드의아노머화방법 |
-
1995
- 1995-03-24 US US08/410,258 patent/US5633367A/en not_active Expired - Lifetime
-
1996
- 1996-03-11 CA CA002171522A patent/CA2171522A1/en not_active Abandoned
- 1996-03-12 DK DK96301685T patent/DK0735043T3/da active
- 1996-03-12 EP EP96301685A patent/EP0735043B1/de not_active Expired - Lifetime
- 1996-03-12 DE DE69600280T patent/DE69600280T2/de not_active Expired - Lifetime
- 1996-03-12 ES ES96301685T patent/ES2117893T3/es not_active Expired - Lifetime
- 1996-03-22 JP JP8066121A patent/JPH08269081A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DK0735043T3 (da) | 1998-10-07 |
ES2117893T3 (es) | 1998-08-16 |
EP0735043A1 (de) | 1996-10-02 |
US5633367A (en) | 1997-05-27 |
CA2171522A1 (en) | 1996-09-25 |
JPH08269081A (ja) | 1996-10-15 |
DE69600280T2 (de) | 1998-10-08 |
EP0735043B1 (de) | 1998-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69628712D1 (de) | Verfahren zur Herstellung von Dihalogenazolopyrimidinen | |
DE69534190D1 (de) | Verfahren zur Herstellung von 1,2-Benzisothiazol-3-onen | |
DE59607656D1 (de) | Verfahren zur Herstellung von Alkylhydrogenchlorsilanen | |
DE59608829D1 (de) | Verfahren zur Herstellung von 1,3-Dimethyl-5-fluor-pyrazol-4-carboxaniliden | |
DE59503847D1 (de) | Verfahren zur Herstellung von 3,5-Dimethylpyrazol-blockierten Polyisocyanaten | |
DE59408701D1 (de) | Verfahren zur Herstellung von 2,3,4,5-Tetrafluor-benzotrifluorid | |
DE69602880D1 (de) | Verfahren zur Herstellung von 1,2-Dichlorethan | |
DE69600280D1 (de) | Verfahren zur Herstellung von einem 2-substituierten 3,3-Difluorfuran | |
DE69408085D1 (de) | Verfahren zur Herstellung von 2,2-Diphenylhexafluorpropanen | |
DE69401368D1 (de) | Verfahren zur Herstellung von 1,4-Dicyano-2-buten | |
DE59303691D1 (de) | Verfahren zur Herstellung von alpha-Chlor- 2,4,6-trimethylacetophenon | |
DE59600661D1 (de) | Verfahren zur Herstellung von d,I-Menthol | |
DE59309922D1 (de) | Verfahren zur Herstellung von substituierten 2,3-Difluorpyridinen | |
DE69508683D1 (de) | Verfahren zur Herstellung von 2,6-Di-tert-alkylcyclohexanol | |
DE69503100D1 (de) | Verfahren zur Herstellung von 3,4-Carandiol | |
DE59401800D1 (de) | Verfahren zur Herstellung von 1,1'-Binaphthylen | |
DE69600385D1 (de) | Verfahren zur Herstellung von Aminonitropyridinen | |
DE59500712D1 (de) | Verfahren zur Herstellung von 4,6-Diaminoresorcin | |
DE69710294D1 (de) | Verfahren zur Herstellung von 3,5,5-Trimethyl-Cyclohexa-3-en-1-on | |
DE69607541D1 (de) | Verfahren zur Herstellung von p-Bromfluorobenzol | |
DE69513008D1 (de) | Verfahren zur Herstellung von Hydroxyalkoxybenzophenonen | |
DE59605105D1 (de) | Verfahren zur Herstellung von substituierten Aminocarbonyltriazolinonen | |
DE59605227D1 (de) | Verfahren zur Herstellung von ortho-Nitro-benzonitrilen | |
DE69502242D1 (de) | Verfahren zur Herstellung von 1,3-dialkyl-2-imidazolidinon | |
DE69600534D1 (de) | Verfahren zur Herstellung von 1,5-Hexadien |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336 |
|
8328 | Change in the person/name/address of the agent |
Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN |